Caracterización clínica y demográfica de pacientes colombianos con rinosinusitis crónica con poliposis nasal
Revista Alergia México · 2024
DOI: 10.29262/ram.v71i1.1349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Alergia México, 2024. Verfasst von Sergio Londoño und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sanofi, Bogotá, Colombia. sergio.londono@sanofi.com. Hauptthemen laut MEDLINE: Nasal Polyps, Rhinosinusitis. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi.
Abstract (Originalsprache)
Introduction
Chronic rhinosinusitis with nasal polyposis (CRSwNP) is associated with a high daily burden of symptoms and a significant impact on health-related quality of life (HRQoL) (HRQoL). To date, the clinical and demographic characteristics of Colombian patients with CRSwNP are unknown.
Objectives
The aim of this study is to present the baseline clinical and demographic characteristics of CRSwNP patients over the age of 18 enrolled in a Patient Support Program (PSP) prior to biologic treatment. Methodology: Descriptive, cross-sectional study performed in a Colombian CRSwNP asthma PSP sponsored by Sanofi from Aug-2021 to Jul-2022. Data was collected from CRSwNP patients, prior to the start of Dupilumab treatment, who consented to the use of their data. The following information was reported: Age, reporting city, treating medical specialty, comorbidities, and persistence of treatment.
Results
339 patients were included, 171 (50.4%) were women and 168 (49.6%) were men (Figure 1). The mean age at Dupilumab treatment initiation was 52.4 years. 62.8% began treatment during adulthood (26-59y), while 34.1% started at elderly (+60y) and 3.1% were young adults (18-25y). Most cases (29.7%) were included in Bogotá, followed by Antioquia (19%), Valle del Cauca (7.3%) and the remaining 44% nationwide (Figure 2). Comorbidities were present in 67.1% of the patients, with diagnosis of allergic rhinitis, atopic dermatitis, asthma, and other non-type 2 inflammatory diseases (Figure 3). Nasal surgical history was present in 89.6% of the patients, most of them with one to three previous surgeries (Figure 4). Continuous treatment was observed in 70.3% of patients for 6 to 12 months, in 21.3% for more than 12 months and in 8.4% for less than 6 months. The most frequently treating medical specialty was otorhinolaryngology (79,6%), followed by allergology (16%) and other medical professionals (4.4%).
Conclusions
There is concordance with the literature on a higher presentation of the disease in women than in men. There is a large proportion of patients with nasal surgical history and type 2 inflammatory comorbidities by the moment of biologic treatment initiation. The care and identification of CRSwNP colombian patients is mainly provided by otorhinolaryngologists, followed by allergologists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sanofi, Bogotá, Colombia. sergio.londono@sanofi.com.
- Sanofi, Bogotá, Colombia.
Förderung
- Sanofi
Zitieren
APA
Londoño, S., Penagos, J. C., Díaz, D., Cadena, P., & Ordoñez, P. R. (2024). Caracterización clínica y demográfica de pacientes colombianos con rinosinusitis crónica con poliposis nasal. Revista Alergia México. https://doi.org/10.29262/ram.v71i1.1349
Vancouver
Londoño S, Penagos JC, Díaz D, Cadena P, Ordoñez PR. Caracterización clínica y demográfica de pacientes colombianos con rinosinusitis crónica con poliposis nasal. Revista Alergia México. 2024. doi:10.29262/ram.v71i1.1349
BibTeX
@article{Londoo2024,
author = {Londoño, Sergio and Penagos, Juan Carlos and Díaz, Diana and Cadena, Pedro and Ordoñez, Paula Rodríguez},
title = {Caracterización clínica y demográfica de pacientes colombianos con rinosinusitis crónica con poliposis nasal},
journal = {Revista Alergia México},
year = {2024},
doi = {10.29262/ram.v71i1.1349}
}
EUVIMED